title: Effective control of rush progression of CD8+ mycosis fungoides with pegylated interferon.
authors.forename: Taku
authors.initials: T
authors.lastname: Fujimura
authors.forename: Ryuhei
authors.initials: R
authors.lastname: Okuyama
authors.forename: Akira
authors.initials: A
authors.lastname: Hashimoto
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Watanabe
authors.forename: Satoshi
authors.initials: S
authors.lastname: Nakagawa
authors.forename: Hachiro
authors.initials: H
authors.lastname: Tagami
authors.forename: Setsuya
authors.initials: S
authors.lastname: Aiba
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D009182:Mycosis Fungoides / Q000276:immunology / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011882:Radiotherapy, High-Energy; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a